2
Adenoviral conjunctivitis Quidel | Rapid Diagnostics | quidel.com | quideleyehealth.com | 800.874.1517 | 858.552.1100 Clinical benefits Identify, isolate and manage contagious patients, preventing spread to other patients and staff. Reduce inappropriate antibiotic use. Offer an accurate, fast, disposable platform that is easy to use. Fast and accurate Results in 10 minutes. 90% sensitivity and 96% specificity. Easy and convenient Disposable test, requires just 4 easy steps. Just sample, dip and read! No additional equipment is needed to administer or interpret. Acute conjunctivitis affects nearly 6.9 million Americans each year. Approximately 50% of cases are misdiagnosed which could result in significant morbidity in patients. 1 Even though viral conjunctivitis is much more commonly seen than bacterial conjunctivitis, 2 at least 60% of conjunctivitis cases are prescribed antibiotics. At Quidel, we believe that kids should not be prescribed antibiotics when they don’t need them. QuickVue Adenoviral conjunctivitis Test is the first rapid, CLIA-waived point-of-care test that detects all known serotypes of adenoviral conjunctivitis. An early and accurate diagnosis may prevent serious complications in the future. With QuickVue Adenoviral conjunctivitis Test you can make a rapid, accurate diagnosis before the patient leaves your office. Rapidly diagnose adenoviral conjunctivitis

Adenoviral conjunctivitis - Quidel Corporation · least 60% of conjunctivitis cases are prescribed antibiotics. At Quidel, we believe that kids should not be prescribed antibiotics

  • Upload
    others

  • View
    4

  • Download
    0

Embed Size (px)

Citation preview

Page 1: Adenoviral conjunctivitis - Quidel Corporation · least 60% of conjunctivitis cases are prescribed antibiotics. At Quidel, we believe that kids should not be prescribed antibiotics

Adenoviral conjunctivitis

Quidel | Rapid Diagnostics | quidel.com | quideleyehealth.com | 800.874.1517 | 858.552.1100

Clinical benefits Identify, isolate and manage contagious patients, preventing spread to other patients and staff.

Reduce inappropriate antibiotic use.

Offer an accurate, fast, disposable platform that is easy to use. Fast and accurate Results in 10 minutes.

90% sensitivity and 96% specificity. Easy and convenient

Disposable test, requires just 4 easy steps.

Just sample, dip and read!

No additional equipment is needed to administer or interpret.

Acute conjunctivitis affects nearly 6.9 million Americans each year. Approximately 50% of cases are misdiagnosed which could result in significant morbidity in patients.1 Even though viral conjunctivitis is much more commonly seen than bacterial conjunctivitis,2 at least 60% of conjunctivitis cases are prescribed antibiotics. At Quidel, we believe that kids should not be prescribed antibiotics when they don’t need them. QuickVue Adenoviral conjunctivitis Test is the first rapid, CLIA-waived point-of-care test that detects all known serotypes of adenoviral conjunctivitis. An early and accurate diagnosis may prevent serious complications in the future. With QuickVue Adenoviral conjunctivitis Test you can make a rapid, accurate diagnosis before the patient leaves your office.

Rapidly diagnose adenoviral conjunctivitis

SS2032400EN00.qxp_Layout 1 1/23/19 9:06 AM Page 1

Page 2: Adenoviral conjunctivitis - Quidel Corporation · least 60% of conjunctivitis cases are prescribed antibiotics. At Quidel, we believe that kids should not be prescribed antibiotics

SL2502 | SS2032400EN00 (01/19)

4-Step Procedure

Performance Characteristics

Sensitivity Specificity

QuickVue Adenoviral conjunctivitis Test – 10 Test Kit: Catalog #20324 QuickVue Adenoviral conjunctivitis External Controls: Catalog #RPS-ADSTD

To order, contact your Quidel Account Manager, call Customer Service at 800.874.1517, or visit quidel.com. For more information on additional eye health products, visit quideleyehealth.com.

Collect sample Assemble test Run test Read results

96%

90%

Refer to the Package Insert for additional performance claims.

Positive

Negative

Invalid

1O’Brien T.P., Jeng B.H., McDonald M. et al. Acute conjunctivitis: truth and misconceptions. Curr Med Res Opin. 2009 Aug; 25(8): 1953-61. 2Kabat A. et al. Improving Recognition of Viral and Bacterial Conjunctivitis. 2018. 3Shekhawat N.S. et al. Antibiotic Prescription Fills for Acute Conjunctivitis among Enrollees in Large United States Managed Care Network. 2018.

SS2032400EN00.qxp_Layout 1 1/23/19 9:06 AM Page 2